theophylline has been researched along with Heart Disease, Ischemic in 58 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of varying concentrations of theophylline on exercise-induced myocardial ischemia were evaluated in patients with stable coronary artery disease." | 9.07 | Effects of intravenous theophylline on exercise-induced myocardial ischemia: II. A concentration-dependent phenomenon. ( Ahlberg, AW; Barbour, MM; Cloutier, DJ; Garber, CE; Heller, GV; McClellan, JR, 1993) |
| "Theophylline has been shown to delay the onset of myocardial ischemia and to prolong exercise duration." | 9.07 | Effects of intravenous theophylline on exercise-induced myocardial ischemia. I. Impact on the ischemic threshold. ( Barbour, MM; Corning, JJ; Dweik, RB; Garber, CE; Heller, GV; McClellan, JR, 1993) |
| "In this study, the antiarrhythmic effects of adenosine on ventricular fibrillation during global (low flow) ischemia were evaluated in isolated guinea pig hearts perfused by the method of Langendorff." | 7.71 | Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation. ( Brodmann, M; Lueger, A; Stark, G; Stark, U, 2001) |
| "Persisting coronary vasoconstrictor tone that is responsive to exogenous adenosine administration has been demonstrated during myocardial ischemia." | 7.68 | Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise. ( Bache, RJ; Homans, DC; Laxson, DD, 1993) |
| "The effects of varying concentrations of theophylline on exercise-induced myocardial ischemia were evaluated in patients with stable coronary artery disease." | 5.07 | Effects of intravenous theophylline on exercise-induced myocardial ischemia: II. A concentration-dependent phenomenon. ( Ahlberg, AW; Barbour, MM; Cloutier, DJ; Garber, CE; Heller, GV; McClellan, JR, 1993) |
| "Theophylline has been shown to delay the onset of myocardial ischemia and to prolong exercise duration." | 5.07 | Effects of intravenous theophylline on exercise-induced myocardial ischemia. I. Impact on the ischemic threshold. ( Barbour, MM; Corning, JJ; Dweik, RB; Garber, CE; Heller, GV; McClellan, JR, 1993) |
| "Previous studies indicate that adenosine supplementation or nitric oxide synthase (NOS) inhibition during reperfusion exert protective effects against myocardial ischemia-reperfusion (I/R) injury." | 3.74 | Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury. ( Bouhaddi, M; Davani, S; Kantelip, JP; Reyssie, H; Rochette, L; Royer, B; Vergely, C, 2007) |
| "In this study, the antiarrhythmic effects of adenosine on ventricular fibrillation during global (low flow) ischemia were evaluated in isolated guinea pig hearts perfused by the method of Langendorff." | 3.71 | Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation. ( Brodmann, M; Lueger, A; Stark, G; Stark, U, 2001) |
| " In additional experimental groups, 8 sulfophenyl-theophylline (SPT, 10 mg/kg), an adenosine receptor inhibitor, was intravenously injected before the 40 min myocardial ischemia (SPT, MPC + SPT and RPC + SPT groups, respectively)." | 3.70 | Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning". ( Inubushi, T; Kinoshita, M; Mitsunami, K; Morikawa, S; Nakae, I; Takaoka, A; Yabe, T, 1999) |
| "Persisting coronary vasoconstrictor tone that is responsive to exogenous adenosine administration has been demonstrated during myocardial ischemia." | 3.68 | Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise. ( Bache, RJ; Homans, DC; Laxson, DD, 1993) |
| "We conclude that 1) in sustained myocardial ischemia, SOD treatment attenuates ischemic injury caused by coronary microembolization by restoration of 5'-nucleotidase activity and augmentation of adenosine release; 2) this beneficial effect of SOD is observed even after coronary microembolization; and 3) the beneficial effects of SOD are attributable to coronary vasodilation produced by augmented adenosine release." | 3.68 | Superoxide dismutase restores contractile and metabolic dysfunction through augmentation of adenosine release in coronary microembolization. ( Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Sato, H; Takashima, S, 1993) |
| "We assessed the effects of the adenosine antagonist 8-(p-sulfophenyl)theophylline (SPT) and adenosine on myocardial infarct size and the incidence of ventricular arrhythmias in five groups of rats: control (nonpreconditioned)+vehicle, control+SPT, preconditioned+vehicle, preconditioned+SPT, and control (nonpreconditioned)+adenosine." | 3.68 | The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts. ( Kloner, RA; Li, Y, 1993) |
| "To test the hypothesis that the endothelium-derived relaxing factor (EDRF) contributes to coronary vasodilation induced by myocardial ischemia, we examined the effect of NG-nitro-L-arginine (a potent and selective inhibitor of EDRF release) on the coronary reactive hyperemic response in the open-chest dogs." | 3.68 | NG-nitro-L-arginine attenuates flow debt repayment in the reactive hyperemic response of the open-chest dog coronary artery: contribution of endothelium-derived relaxing factor. ( Kajikawa, Y; Kusachi, S; Marutani, M; Tsuji, T; Yamasaki, S, 1992) |
| "Adenosine A1 receptors were blocked with 8-p-sulfophenyl theophylline (8-SPT; 20 microM)." | 1.30 | Adenosine receptor blockade enhance glycolysis in hypoperfused guinea-pig myocardium. ( Downey, HF; Gao, ZP; He, MX; Mallet, RT; Sun, J, 1997) |
| "Adenosine has several potentially cardioprotective effects." | 1.30 | Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts. ( Grund, F; Ilebekk, A; Jynge, P; Kirkebøen, KA; Offstad, J; Sommerschild, HT, 1997) |
| "Adenosine has several potentially cardioprotective effects including vasodilatation, reduction in heart rate and alterations in metabolism." | 1.30 | Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban. ( Deindl, E; Ilebekk, A; Jynge, P; Kirkebøen, KA; Lunde, PK; Sommerschild, HT, 1999) |
| "(3) Treatment with acadesine (2." | 1.29 | Acadesine extends the window of protection afforded by ischaemic preconditioning. ( Burckhartt, B; Cohen, MV; Downey, JM; Mullane, KM; Tsuchida, A; Yang, XM, 1994) |
| "Adenosine has been identified as a factor in the protection afforded against regional tissue necrosis by such preconditioning." | 1.29 | Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. ( Cave, AC; Collis, CS; Downey, JM; Hearse, DJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.72) | 18.7374 |
| 1990's | 47 (81.03) | 18.2507 |
| 2000's | 8 (13.79) | 29.6817 |
| 2010's | 2 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scalone, G | 1 |
| Coviello, I | 1 |
| Barone, L | 1 |
| Pisanello, C | 1 |
| Sestito, A | 1 |
| Lanza, GA | 1 |
| Crea, F | 3 |
| Abd-Elfattah, AS | 1 |
| Ding, M | 1 |
| Jessen, ME | 1 |
| Wechsler, AS | 1 |
| Bradamante, S | 1 |
| Barenghi, L | 1 |
| Piccinini, F | 1 |
| Bertelli, AA | 1 |
| De Jonge, R | 2 |
| Beemster, P | 1 |
| De Jong, JW | 2 |
| Efimova, NIu | 1 |
| Chernov, VI | 1 |
| Efimova, IIu | 1 |
| Akhmedov, ShD | 1 |
| Podoksenov, IuK | 1 |
| Lishmanov, IuB | 1 |
| GHIA, G | 1 |
| MEREU, D | 1 |
| Asanuma, H | 1 |
| Minamino, T | 4 |
| Sanada, S | 1 |
| Ogita, H | 1 |
| Kim, J | 1 |
| Fujita, M | 1 |
| Hirata, A | 1 |
| Tsukamoto, O | 1 |
| Ogai, A | 1 |
| Node, K | 3 |
| Hori, M | 6 |
| Tomoike, H | 1 |
| Kitakaze, M | 5 |
| Davani, S | 1 |
| Vergely, C | 1 |
| Royer, B | 1 |
| Bouhaddi, M | 1 |
| Reyssie, H | 1 |
| Rochette, L | 1 |
| Kantelip, JP | 1 |
| Armstrong, S | 4 |
| Downey, JM | 8 |
| Ganote, CE | 4 |
| Morioka, T | 1 |
| Shinozaki, Y | 1 |
| Chujo, M | 1 |
| Mori, H | 1 |
| Takeda, H | 1 |
| Inoue, M | 2 |
| Gao, ZP | 2 |
| Downey, HF | 2 |
| Fan, WL | 1 |
| Mallet, RT | 2 |
| Barbour, MM | 2 |
| Garber, CE | 2 |
| Ahlberg, AW | 1 |
| Cloutier, DJ | 1 |
| McClellan, JR | 2 |
| Heller, GV | 2 |
| Vegh, A | 1 |
| Papp, JG | 1 |
| Parratt, JR | 1 |
| Rynning, SE | 1 |
| Brunvand, H | 1 |
| Birkeland, S | 1 |
| Hexeberg, E | 1 |
| Grong, K | 1 |
| Bugge, E | 1 |
| Ytrehus, K | 1 |
| Liu, GS | 1 |
| Richards, SC | 1 |
| Olsson, RA | 1 |
| Mullane, K | 1 |
| Walsh, RS | 3 |
| Hoshida, S | 1 |
| Kuzuya, T | 2 |
| Nishida, M | 1 |
| Yamashita, N | 1 |
| Oe, H | 1 |
| Kamada, T | 2 |
| Tada, M | 1 |
| Tsuchida, A | 2 |
| Daly, JJ | 1 |
| Thornton, JD | 1 |
| Cohen, MV | 4 |
| Baxter, GF | 2 |
| Marber, MS | 1 |
| Patel, VC | 1 |
| Yellon, DM | 2 |
| Bertolet, BD | 1 |
| Belardinelli, L | 1 |
| Kerensky, R | 1 |
| Hill, JA | 1 |
| Zhao, ZQ | 1 |
| Nakanishi, K | 1 |
| McGee, DS | 1 |
| Tan, P | 1 |
| Vinten-Johansen, J | 1 |
| Yang, XM | 1 |
| Burckhartt, B | 1 |
| Mullane, KM | 1 |
| Laxson, DD | 2 |
| Homans, DC | 1 |
| Bache, RJ | 2 |
| Schwartz, LM | 1 |
| Raschke, P | 1 |
| Becker, BF | 1 |
| Gerlach, E | 1 |
| Duncker, DJ | 2 |
| Lindstrom, P | 1 |
| Urabe, K | 1 |
| Miura, T | 2 |
| Iwamoto, T | 1 |
| Ogawa, T | 1 |
| Goto, M | 3 |
| Sakamoto, J | 2 |
| Iimura, O | 1 |
| Cave, AC | 1 |
| Collis, CS | 1 |
| Hearse, DJ | 1 |
| Gaspardone, A | 2 |
| Iamele, M | 1 |
| Tomai, F | 2 |
| Versaci, F | 1 |
| Pellegrino, A | 1 |
| Chiariello, L | 2 |
| Gioffré, PA | 2 |
| Takashima, S | 1 |
| Sato, H | 1 |
| Dweik, RB | 1 |
| Corning, JJ | 1 |
| Li, Y | 1 |
| Kloner, RA | 1 |
| Pisarenko, OI | 1 |
| Tskitishvily, OV | 1 |
| Studneva, IM | 1 |
| Serebryakova, LI | 1 |
| Korchazhkina, OV | 1 |
| Bouchard, JF | 1 |
| Lamontagne, D | 1 |
| van Wylen, DG | 1 |
| Hashimura, K | 1 |
| Kijima, Y | 1 |
| Matsu-ura, Y | 1 |
| Ueda, T | 1 |
| Kato, Y | 1 |
| Mori, I | 1 |
| Sun, J | 1 |
| He, MX | 1 |
| Gryglewski, RJ | 1 |
| Chlopicki, S | 1 |
| Niezabitowski, P | 1 |
| Jakubowski, A | 1 |
| Lomnicka, M | 1 |
| Zaman, MJ | 1 |
| Kerac, M | 1 |
| Matherne, GP | 1 |
| Linden, J | 1 |
| Byford, AM | 1 |
| Gauthier, NS | 1 |
| Headrick, JP | 1 |
| Danesi, A | 1 |
| Perino, M | 1 |
| Ghini, AS | 1 |
| Ruggeri, G | 1 |
| Askenasy, N | 1 |
| Navon, G | 1 |
| Sommerschild, HT | 2 |
| Grund, F | 1 |
| Offstad, J | 1 |
| Jynge, P | 2 |
| Ilebekk, A | 2 |
| Kirkebøen, KA | 2 |
| Ismail, JA | 1 |
| McDonough, KH | 1 |
| Miki, T | 1 |
| Bünger, R | 1 |
| Suzuki, K | 1 |
| Shimamoto, K | 1 |
| Cohen, G | 1 |
| Shirai, T | 1 |
| Weisel, RD | 1 |
| Rao, V | 1 |
| Merante, F | 1 |
| Tumiati, LC | 1 |
| Mohabeer, MK | 1 |
| Borger, MA | 1 |
| Li, RK | 1 |
| Mickle, DA | 1 |
| Takaoka, A | 1 |
| Nakae, I | 1 |
| Mitsunami, K | 1 |
| Yabe, T | 1 |
| Morikawa, S | 1 |
| Inubushi, T | 1 |
| Kinoshita, M | 1 |
| Schreieck, J | 1 |
| Richardt, G | 1 |
| Lunde, PK | 1 |
| Deindl, E | 1 |
| Komamura, K | 1 |
| Kosaka, H | 1 |
| Yamamoto, M | 1 |
| Egashira, K | 1 |
| Arimura, K | 1 |
| Tada, H | 1 |
| Shimokawa, H | 1 |
| Takeshita, A | 1 |
| Stark, U | 1 |
| Brodmann, M | 1 |
| Lueger, A | 1 |
| Stark, G | 1 |
| Schaefer, S | 1 |
| Correa, SD | 1 |
| Valente, RJ | 1 |
| Laslett, LJ | 1 |
| Liem, DA | 1 |
| Verdouw, PD | 1 |
| Ploeg, H | 1 |
| Kazim, S | 1 |
| Marutani, M | 1 |
| Kusachi, S | 1 |
| Kajikawa, Y | 1 |
| Yamasaki, S | 1 |
| Tsuji, T | 1 |
7 trials available for theophylline and Heart Disease, Ischemic
| Article | Year |
|---|---|
Brief low-workload myocardial ischaemia induces protection against exercise-related increase of platelet reactivity in patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Cross-Over Studies; Exercise; Exercise Test; Female; Flow Cytometry; | 2010 |
Effects of intravenous theophylline on exercise-induced myocardial ischemia: II. A concentration-dependent phenomenon.
Topics: Adenosine; Aged; Blood Pressure; Cardiac Complexes, Premature; Chronic Disease; Coronary Disease; Do | 1993 |
Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action.
Topics: Aged; Coronary Angiography; Echocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Mid | 1993 |
Effects of intravenous theophylline on exercise-induced myocardial ischemia. I. Impact on the ischemic threshold.
Topics: Blood Pressure; Double-Blind Method; Electrocardiography; Exercise; Heart; Heart Rate; Humans; Infus | 1993 |
Effect of theophylline on adaptation of the heart to myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with stable angina pectoris.
Topics: Adaptation, Physiological; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Co | 1997 |
Effects of A1 adenosine receptor blockade on the warm-up phenomenon.
Topics: Aged; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Pu | 1997 |
Blockade of adenosine receptors with aminophylline limits ischemic preconditioning in human beings.
Topics: Aminophylline; Angioplasty; Cardiotonic Agents; Coronary Disease; Electrocardiography; Female; Human | 2001 |
51 other studies available for theophylline and Heart Disease, Ischemic
| Article | Year |
|---|---|
On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic crossclamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor.
Topics: Adenine; Adenosine Deaminase Inhibitors; Animals; Chromatography, High Pressure Liquid; Constriction | 2012 |
Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Topics: Adenosine; Animals; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Tec | 2003 |
[Pharmacological prevention of cerebrovascular complications in cardiac patients after coronary artery bypass surgery].
Topics: Benzamides; Cerebrovascular Circulation; Cognition Disorders; Coronary Artery Bypass; Drug Combinati | 2003 |
[CLINICAL OBSERVATIONS AND THERAPEUTIC RESULTS IN SUBJECTS WITH ISCHEMIC CARDIOPATHY TREATED WITH AN ENZYME COMPLEX ASSOCIATED WITH A VASODILATOR DRUG].
Topics: Adenosine Triphosphate; Coronary Disease; Drug Therapy; Electrocardiography; Flavin Mononucleotide; | 1964 |
A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts.
Topics: Adenosine; Amlodipine; Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Do | 2005 |
Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
Topics: Adenosine; Animals; Arginine; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Enzyme Inh | 2007 |
Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor.
Topics: Adenosine; Animals; Cell Size; Cell Survival; Cells, Cultured; Glucose; Heart; Myocardial Ischemia; | 1994 |
Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
Topics: Adenosine; Animals; Antihypertensive Agents; Cells, Cultured; Glucose; Myocardial Infarction; Myocar | 1994 |
In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C.
Topics: Animals; In Vitro Techniques; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naphth | 1995 |
Bidirectional effects of aminophylline on myocardial ischemia.
Topics: Adenosine; Aminophylline; Animals; Coronary Circulation; Dogs; Heart; Lactates; Lactic Acid; Myocard | 1995 |
Does interstitial adenosine mediate acute hibernation of guinea pig myocardium?
Topics: 5'-Nucleotidase; Acute Disease; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; C | 1995 |
Pronounced antiarrhythmic effects of preconditioning in anaesthetized dogs: is adenosine involved?
Topics: Adenosine; Anesthesia, General; Animals; Arrhythmias, Cardiac; Blood Flow Velocity; Blood Pressure; | 1995 |
Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion.
Topics: Adenosine; Animals; Cats; Coronary Circulation; Doxazosin; Heart; Hemodynamics; Male; Myocardial Con | 1995 |
Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
Topics: Alkaloids; Animals; Benzophenanthridines; In Vitro Techniques; Male; Myocardial Infarction; Myocardi | 1995 |
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
Topics: Adenosine; Animals; Antihypertensive Agents; Female; In Vitro Techniques; Male; Myocardial Infarctio | 1994 |
Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
Topics: Animals; Dogs; Female; Leukocyte Count; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium | 1994 |
Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
Topics: Animals; Glyburide; Guanidines; Ketamine; Myocardial Infarction; Myocardial Ischemia; Myocardium; Pi | 1994 |
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
Topics: Adenosine; Animals; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardia | 1994 |
Adenosine blockade as primary therapy for ischemia-induced accelerated idioventricular rhythm: rationale and potential clinical application.
Topics: Adenosine; Aged; Arrhythmia, Sinus; Bradycardia; Female; Humans; Male; Myocardial Ischemia; Streptok | 1994 |
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Animals; Myocardial Infarction; Myocardial Ische | 1994 |
Acadesine extends the window of protection afforded by ischaemic preconditioning.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Female; Male; Myocardial Infarction; Myocardial Isch | 1994 |
Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise.
Topics: Adenosine; Adenosine Deaminase; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dog | 1993 |
Adenosine contributes to neutrophil-mediated loss of myocardial function in post-ischemic guinea-pig hearts.
Topics: Adenosine; Adenosine Deaminase; Animals; Blood Flow Velocity; Cardiac Output; Coronary Circulation; | 1993 |
Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Animals; Coronary Ves | 1993 |
Adenosine and A1 selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes.
Topics: Adenosine; Animals; Carbachol; Cell Death; Cells, Cultured; Iodoacetates; Iodoacetic Acid; Isoproter | 1993 |
Preconditioning enhances myocardial resistance to postischaemic myocardial stunning via adenosine receptor activation.
Topics: Animals; Disease Models, Animal; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reper | 1993 |
Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart.
Topics: Adenosine; Animals; Coronary Circulation; Disease Models, Animal; Male; Myocardial Contraction; Myoc | 1993 |
Superoxide dismutase restores contractile and metabolic dysfunction through augmentation of adenosine release in coronary microembolization.
Topics: 5'-Nucleotidase; Adenosine; Animals; Coronary Circulation; Dogs; Embolism; Injections; Lactates; Lac | 1993 |
The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts.
Topics: Adenosine; Animals; Arrhythmias, Cardiac; Female; Heart; Hemodynamics; Myocardial Ischemia; Myocardi | 1993 |
Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release.
Topics: Adenosine; Adrenergic alpha-Antagonists; Animals; Catecholamines; Heart; Hemodynamics; Hypoxia; In V | 1995 |
Metabolic effects of ischemic preconditioning and adenosine receptor blockade in dogs.
Topics: Adenosine; Animals; Creatine; Dogs; Female; Lactic Acid; Male; Myocardial Ischemia; Purinergic P1 Re | 1996 |
Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury.
Topics: Adenosine Triphosphate; Animals; Coronary Vessels; Endothelium, Vascular; Glyburide; In Vitro Techni | 1996 |
Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection.
Topics: Adenosine; Animals; Female; Heart; Hemodynamics; Hypoxanthines; In Vitro Techniques; Inosine; Ischem | 1996 |
Adenosine receptor blockade enhance glycolysis in hypoperfused guinea-pig myocardium.
Topics: Adenosine; Animals; Enzyme Activation; Glucose; Glycogen; Glycolysis; Guinea Pigs; In Vitro Techniqu | 1997 |
Ischaemic cardiac hyperaemia: role of nitric oxide and other mediators.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Animals; Coronary Circulation; Cyclic GMP; Cyclooxygenase I | 1996 |
Protection against global ischemia in the rabbit isolated heart 24 hours after transient adenosine A1 receptor activation.
Topics: Adenosine; Animals; Blood Pressure; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; | 1997 |
Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.
Topics: Adenosine; Analysis of Variance; Animals; Cell Membrane; Coronary Vessels; Female; Heart; Heart Rate | 1997 |
Intermittent ischemia: energy metabolism, cellular volume regulation, adenosine and insights into preconditioning.
Topics: Adenosine; Animals; Cell Size; Creatine; Energy Metabolism; Glyburide; Glycogen; Glycolysis; In Vitr | 1997 |
Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts.
Topics: Adenosine; Animals; Animals, Newborn; Creatine Kinase; Myocardial Contraction; Myocardial Ischemia; | 1997 |
The role of coronary flow and adenosine in postischemic recovery of septic rat hearts.
Topics: Animals; Bacteremia; Blood Pressure; Coronary Circulation; Escherichia coli Infections; Heart Rate; | 1998 |
Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Pressure; Enzyme Inh | 1998 |
Optimal myocardial preconditioning in a human model of ischemia and reperfusion.
Topics: Adenosine; Dose-Response Relationship, Drug; Humans; Ischemic Preconditioning, Myocardial; Myocardia | 1998 |
Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning".
Topics: Adenosine Triphosphate; Animals; Energy Metabolism; Hydrogen-Ion Concentration; Infusions, Intraveno | 1999 |
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
Topics: Adenine; Adenosine; Aminoimidazole Carboxamide; Animals; Caffeine; Creatine Kinase; Electrocardiogra | 1999 |
Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
Topics: Adenosine; Animals; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiotonic Agents; Ener | 1999 |
Intracoronary administration of adenosine triphosphate increases coronary blood flow and attenuates the severity of myocardial ischemic injury in dogs.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Coronary Circulation; Dogs; Enzyme Inhibitors | 1999 |
Ischemic preconditioning and glucose metabolism during low-flow ischemia: role of the adenosine A1 receptor.
Topics: Adenosine; Animals; Glucose; Glycolysis; Ischemic Preconditioning, Myocardial; Male; Myocardial Isch | 1999 |
Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Vessels; Dogs; Dose-Response Relatio | 2000 |
Antiarrhythmic effects of adenosine on ischemia-induced ventricular fibrillation.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Dipyridamole; Female; Guinea Pigs; In Vitro Techniques; | 2001 |
Sites of action of adenosine in interorgan preconditioning of the heart.
Topics: Adenosine; Animals; Blood Pressure; Coronary Vessels; Ganglionic Blockers; Heart Rate; Hexamethonium | 2002 |
NG-nitro-L-arginine attenuates flow debt repayment in the reactive hyperemic response of the open-chest dog coronary artery: contribution of endothelium-derived relaxing factor.
Topics: Adenosine; Animals; Arginine; Coronary Vessels; Dogs; Myocardial Ischemia; Nitric Oxide; Nitroargini | 1992 |